Chief Executive Officer & Founder Neurxstem
OCT 18, 2016 1:40 PM PDT
The Future of Science and Live Q&A
Presented at:
SyncD³ - Where drug discovery & development meet
Speakers
-
Richard Visconti, PhD
Cell Sciences Innovation, Merck Research Laboratories, Merck
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...